Mel-Frontier Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$12.9K
- Investors
-
3
Mel-Frontier General Information
Description
Manufacturer of bioabsorbable medical devices designed to facilitate internal bone fixation. The company's technology utilizes a proprietary magnesium alloy and precision processing to provide bone fixation screws, tissue staples, and plates, enabling orthopedic surgeons and healthcare providers to perform surgeries without the need for secondary removal procedures, as the implants naturally decompose and are absorbed by the body.
Contact Information
Website
www.mel-frontier.jpCorporate Office
- 8th Floor, Ikebukuro Toei Building
- 4-26-13 Higashi-Ikebukuro
- Toshima-ku, Tokyo
- Japan
Corporate Office
- 8th Floor, Ikebukuro Toei Building
- 4-26-13 Higashi-Ikebukuro
- Toshima-ku, Tokyo
- Japan
Mel-Frontier Timeline
Mel-Frontier Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 04-Mar-2026 | $12.9K | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 02-Oct-2025 | Completed | Generating Revenue | |||
| 2. Secondary Transaction - Private | $1.33M | Completed | Generating Revenue | |||
| 1. Seed Round | 16-Oct-2020 | $1.33M | $1.33M | Completed | Generating Revenue |
Mel-Frontier Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Mel-Frontier Patents
Mel-Frontier Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3342901-A1 | Alloy member usable in organisms and production method therefor | Active | 20-Aug-2015 | ||
| EP-3342901-A4 | Alloy member usable in organisms and production method therefor | Active | 20-Aug-2015 | ||
| EP-3342901-B1 | Alloy member usable in organisms and production method therefor | Active | 20-Aug-2015 | ||
| US-10842911-B2 | Alloy member usable in organisms and production method therefor | Active | 20-Aug-2015 | ||
| US-20180264166-A1 | Alloy member usable in organisms and production method therefor | Active | 20-Aug-2015 | A61L27/047 |
Mel-Frontier Signals
Mel-Frontier Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mebuki Financial Group | Corporation | |||
| JAPAN CONVENTION SERVICES | Accelerator/Incubator | |||
| SRD Holdings (Japan) | Corporation | Minority |
Mel-Frontier FAQs
-
When was Mel-Frontier founded?
Mel-Frontier was founded in 2016.
-
Where is Mel-Frontier headquartered?
Mel-Frontier is headquartered in Toshima-ku, Japan.
-
What is the size of Mel-Frontier?
Mel-Frontier has 10 total employees.
-
What industry is Mel-Frontier in?
Mel-Frontier’s primary industry is Surgical Devices.
-
Is Mel-Frontier a private or public company?
Mel-Frontier is a Private company.
-
What is Mel-Frontier’s current revenue?
The current revenue for Mel-Frontier is .
-
How much funding has Mel-Frontier raised over time?
Mel-Frontier has raised $2.95M.
-
Who are Mel-Frontier’s investors?
Mebuki Financial Group, JAPAN CONVENTION SERVICES, and SRD Holdings (Japan) have invested in Mel-Frontier.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process